Scopus Biopharma Inc - ESG Rating & Company Profile powered by AI
The ESG rating includes 17 United Nations SDGs including: 'Quality Education', 'Climate Action' and 'Life on Land'. If you work at Scopus Biopharma Inc and you would like to licence your ESG aseessment, please get in touch. The report of Scopus Biopharma Inc employs intelligence from across the web and also from public filings by Scopus Biopharma Inc.
Scopus Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Scopus Biopharma Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Scopus Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Scopus Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Scopus Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Scopus Biopharma Inc offer flexible work?
Sign up for free to unlockDoes Scopus Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Scopus Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Scopus Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes Scopus Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Scopus Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Scopus Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Scopus Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Scopus Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Scopus Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Scopus Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes Scopus Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes Scopus Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Scopus Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Scopus Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.